Targovax ASA logo

TRVX - Targovax ASA News Story

NOK8.05 0.4  4.6%

Last Trade - 3:25pm

Sector
Healthcare
Size
Micro Cap
Market Cap £49.3m
Enterprise Value £46.2m
Revenue £238k
Position in Universe 989th / 1784

Targovax ASA: Issuance of restricted stock unites (RSUs) to the chairman of the board of directors

Thu 1st March, 2018 6:00am
Targovax ASA: Issuance of restricted stock unites (RSUs) to the chairman of the board of directors Reference is made to the extraordinary general meeting of Targovax ASA (the "Company") on 30 November 2017, where Patrick Vink was elected as chairman of the Company's board of directors and the Company was authorized to issue restricted stock units ("RSUs") to Patrick Vink. The RSUs are non-transferable and each RSU gives the right and obligation to acquire one share in the Company at a price of NOK 0.10 per share (corresponding to the nominal value of the shares) subject to satisfaction of the applicable vesting conditions.

Patrick Vink has resolved to receive his full board remuneration, as determined by the Company's extraordinary general meeting in November 2017, in the form of RSUs and the Company has resolved to issue 11,131 RSUs to Patrick Vink. Following the issuance, Patrick Vink holds 11,131 RSUs and no shares in the Company.

The number of RSUs issued is calculated on the basis of his relative board remuneration of NOK 162,740 divided by the market price of the Company's shares calculated as the average share price for the 10 trading days prior to the extraordinary general meeting, being NOK 14.62 per share.

###

For further information please contact:
Erik Digman Wiklund, CFO
Phone: +47 413 33 536
Email: erik.wiklund@targovax.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Targovax ASA via Globenewswire

© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.